Survey Finds Americans Weigh Ozempic Costs Against Retirement Savings

A survey examined by NewsNation found that a growing share of Americans facing the cost of GLP-1 weight-loss medications, including Ozempic, say they cannot keep up with both the drug and their retirement savings at the same time, the network reported. The framing of the report — "Ozempic or retirement" — puts a name to a tension financial advisers have discussed in general terms for months: a prescription bill that can exceed a typical co-pay, competing directly with a 401(k) contribution or an individual retirement account deposit.

The network's coverage, the only account of the survey available to this desk, did not disclose the survey's sponsor, sample size, or the exact share of respondents choosing one option over the other. What the report does establish is that respondents described the trade-off as something they are actually making, not a hypothetical. Readers looking for the underlying figures should consult NewsNation's original report directly.

Why Are GLP-1 Drugs Competing With Retirement Contributions?

GLP-1 receptor agonists, the drug class that includes Ozempic and the weight-loss version Wegovy, are frequently excluded from insurance formularies when prescribed for weight management rather than diabetes, leaving patients to pay list price or pursue manufacturer discounts on their own. For a household budgeting month to month, a drug payment that recurs every cycle behaves like a new, fixed expense — closer to a mortgage or car payment than a one-time medical bill. Retirement contributions, by contrast, are often the easiest line item to adjust in the short term, because trimming a 401(k) contribution does not carry the same immediate consequence as missing a medication dose or a loan payment. That asymmetry — one obligation feels urgent, the other feels deferrable — helps explain why a recurring prescription can crowd out savings even when the dollar amounts are comparable.

What Options Do Households Have Before Cutting Retirement Savings?

Financial planners generally advise working through a short list before reducing retirement contributions in response to a new medical expense. Employer matching funds are typically the first thing to protect: an employee who stops contributing enough to capture a full 401(k) match is effectively forfeiting money the employer would otherwise add, along with that money's own investment growth over time. Beyond the match, savers can look into manufacturer savings cards for GLP-1 drugs, check whether a health savings account or flexible spending account can cover the medication on a pretax basis, or revisit insurance options during open enrollment for a plan whose formulary includes the drug. For savers who keep contributing but want to understand where that money is invested, income-oriented sectors such as utilities are one option covered in HTT's recent explainer on the Vanguard Utilities ETF.

Does This Reflect a Broader Pattern in Household Budgets?

The Ozempic-versus-retirement question fits alongside other recent findings about how Americans are reassessing financial priorities under tighter budgets. A separate survey centered on San Francisco found that respondents hold a largely negative view of credit scores as a measure of financial health, according to a report on that survey. The two findings measure different things, but both point to households reconsidering which financial benchmarks and obligations deserve priority when money is tight.

What Should Someone Do If They Face This Choice?

Advisers caution against treating the decision as all-or-nothing. A saver can often reduce, rather than eliminate, a retirement contribution temporarily while covering a new drug expense, preserving at minimum the portion of a 401(k) match that costs nothing extra out of pocket. Reviewing the actual price of a GLP-1 prescription after manufacturer coupons or HSA treatment — rather than the sticker price quoted at a pharmacy counter — is also a common first step, since discounts can change the calculation significantly before any change is made to a retirement account.

Where Does the Original Survey Stand Now?

NewsNation's report frames the trade-off as a growing concern without publishing the full data set behind it in the material reviewed for this article. The network has not indicated whether it will release additional detail on the survey's methodology or results.

mindfulAI Keyboard — An iPhone keyboard that rewrites a draft in a tone you pick. Four free AI actions a day.